Etanercept
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Drug reference
lisocabtagene maraleucel
Antineoplastic agent (CD19 CAR-T cell therapy)
Antineoplastic agent (CD19 CAR-T cell therapy)
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
12 major
SEVERE in our sources
PREGNANCY
—
not curated
Top interactionssee all 12 →
- EtanerceptSevereDatabaseDDInter
- FingolimodSevereDatabaseDDInter
- GolimumabSevereDatabaseDDInter
- InfliximabSevereDatabaseDDInter
Mechanism
Not yet extracted
Drug interactions
Fingolimod
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Golimumab
Severe
Database
Clinical effect not specified
Source: DDInter
Infliximab
Severe
Database
Clinical effect not specified
Source: DDInter
Leflunomide
Severe
Database
Clinical effect not specified
Source: DDInter
Measles Virus Vaccine Live Attenuated
Severe
Database
Clinical effect not specified
Source: DDInter
Natalizumab
Severe
Database
Clinical effect not specified
Source: DDInter
Ozanimod
Severe
Database
Clinical effect not specified
Source: DDInter
Rotavirus Vaccine
Severe
Database
Clinical effect not specified
Source: DDInter
Siponimod
Severe
Database
Clinical effect not specified
Source: DDInter
Talimogene Laherparepvec
Severe
Database
Clinical effect not specified
Source: DDInter
Teriflunomide
Severe
Database
Clinical effect not specified
Source: DDInter
Other Unclassified drugs
Ask House about lisocabtagene maraleucel
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Harrison 22e·Verified: 2026-05-10 · House clinical team